Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension



Rating:

Share or cite this content

Citations should be made in the following way:
A. Mutgan (Graz, Austria), K. Jandl (Graz, Austria), L. Marsh (Graz, Austria), J. Hoffmann (Graz, Austria), E. Gschwandtner (Vienna, Austria), W. Klepetko (Vienna, Austria), A. Heinemann (Graz, Austria), H. Olschewski (Graz, Austria), A. Olschewski (Graz, Austria), M. Wygrecka (Giessen, Germany), G. Kwapiszewska (Graz, Austria). Pentastatin, matrikine of the type IV collagen a5 drives pulmonary hypertension via endothelial dysfunction. 594

Member's Comments

No comment yet.

Related content which might interest you: Refractory remodeling of intrapulmonary arteries by type V collagen, apoptosis and endothelial activation in experimental systemic sclerosis Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Polymorphisms in the type IV collagen alpha3 gene and the risk of COPD Source: Eur Respir J 2008; 32: 35-41 Year: 2008 Pathobiology of pulmonary arterial hypertension Source: Eur Respir J 2002; 20: 1559-1572 Year: 2002 Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats Source: Eur Respir J 2011; 37: 1104-1118 Year: 2011 Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD Source: Eur Respir J 2006; 28: 556-562 Year: 2006 Involvement of FHL1 in vascular remodelling Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling Year: 2006 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Late stage of experimental pulmonary fibrosis is modulated by collagen V Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Interaction between vascular collagen V and endothelial apoptosis reinforce the vascular pathway in SSC pathogenesis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Mast cells promote lung vascular remodelling in pulmonary hypertension Source: Eur Respir J 2011; 37: 1400-1410 Year: 2011 Pathobiology of pulmonary arterial hypertension and right ventricular failure Source: Eur Respir J 2012; 40: 1555-1565 Year: 2012 Pulmonary hypertension: the science behind the disease spectrum Source: Eur Respir Rev 2012; 21: 19-26 Year: 2012 Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats Source: Eur Respir J 2011; 37: 813-822 Year: 2011 Effects of type I, II and III interferons on endothelin-1 release by human pulmonary artery smooth muscle cells Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Alternative Polyadenylation(APA) modulates extracellular matrix deposition in pulmonary hypertension Source: ERS Lung Science Conference 2018 Year: 2018 Pulmonary interstitium remodeling by collagen V is associated with profibrotic cytocines in experimental systemic sclerosis Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 MMP expression and abnormal lung permeability are important determinants of outcome in IPF Source: Eur Respir J 2009; 33: 77-84 Year: 2009 Collagen V and decorin is involved in systemic sclerosis pulmonary fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011